Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022

Jan 19, 2024
1 min read

Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022, in JAMA Psychiatry

key takeaway: "Trends in the number of incident prescriptions dispensed nationally for Schedule II (C-II) stimulant and nonstimulant medications for attention-deficit/hyperactivity disorder (ADHD) significantly increased during the COVID-19 pandemic, exceeding prepandemic rates, notably in young adults and women. Incident prescription trends for antidepressants, benzodiazepines, and buprenorphine for opioid use disorder did not significantly change."

Recent Posts

See All

Mental Health of Youths Who Use Puberty Blockers

Mental Health of Youths Who Use Puberty Blockers, in JAMA Network Open key takeaway: "prescription of a puberty blocker was associated with decreased adjusted odds of mood disorder and suicidal though

Availability of Naloxone in Retail Pharmacies Following Introduction of Over-the-Counter Status

Availability of Naloxone in Retail Pharmacies Following Introduction of Over-the-Counter Status, in JAMA Network Open key takeaway: "61.4% of pharmacies reported same-day naloxone availability without

A Decade of Innovations and Insights from FDA’s “The Real Cost” Campaigns and Youth Prevention Efforts

A Decade of Innovations and Insights from FDA’s “The Real Cost” Campaigns and Youth Prevention Efforts, special issue of American Journal of Preventive Medicine key takeaway, from the conclusion artic

PROMOTING BEHAVIORAL HEALTH TEAM

A Committee of the Partnership for a Healthier Fairfax

Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022

Recent Posts

Comments